rs730882216
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PP3_StrongPP5_Very_Strong
The NM_020401.4(NUP107):c.303G>A(p.Met101Ile) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.00000821 in 1,461,574 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_020401.4 missense, splice_region
Scores
Clinical Significance
Conservation
Publications
- Galloway-Mowat syndrome 7Inheritance: AR Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
- nephrotic syndrome, type 11Inheritance: AR Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- ovarian dysgenesis 6Inheritance: AR Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- 46 XX gonadal dysgenesisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- familial idiopathic steroid-resistant nephrotic syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Galloway-Mowat syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| NUP107 | NM_020401.4 | c.303G>A | p.Met101Ile | missense_variant, splice_region_variant | Exon 4 of 28 | ENST00000229179.9 | NP_065134.1 | |
| NUP107 | NM_001330192.2 | c.216G>A | p.Met72Ile | missense_variant, splice_region_variant | Exon 4 of 28 | NP_001317121.1 | ||
| NUP107 | XM_005269037.5 | c.303G>A | p.Met101Ile | missense_variant, splice_region_variant | Exon 4 of 27 | XP_005269094.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD2 exomes AF: 0.00000399 AC: 1AN: 250664 AF XY: 0.00000738 show subpopulations
GnomAD4 exome AF: 0.00000821 AC: 12AN: 1461574Hom.: 0 Cov.: 30 AF XY: 0.00000825 AC XY: 6AN XY: 727080 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
not provided Pathogenic:2
Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; RNA studies demonstrate a damaging effect that leads to decreased protein expression (PMID: 28280135); This variant is associated with the following publications: (PMID: 38136965, 28117080, 28280135, 25558065, 30179222) -
- -
Galloway-Mowat syndrome 7 Pathogenic:2
- -
This variant is interpreted as a Pathogenic for Galloway-Mowat syndrome 7. The following ACMG Tag(s) were applied: PM2 => Absent from controls (or at extremely low frequency if recessive) in Exome Sequencing Project, 1000 Genomes Project, or Exome Aggregation Consortium. PS3 => Well-established functional studies show a deleterious effect (PMID:30179222). PP1-Strong => PP1 upgraded in strength to Strong (PMID:28280135; 30179222; 25558065). PM3 =>Multiple unrelated affected individuals homozygous for the variant (PMID:28280135; 30179222; 25558065; 28117080) -
Global developmental delay;C3554634:Light complexion;CN228292:Early onset focal segmental glomerulosclerosis Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at